Abeona Therapeutics Inc.
ABEONasdaqCIK 318306HealthcareFiscal year ends Dec 31
Reports and events: 331 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2314:38 ET | SCHEDULE 13D | Ownership report, active investor | 0001477932-26-006433 |
| 2026-09-1512:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-042702 |
| 2026-08-1307:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-037576 |
| 2026-08-1307:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-037575 |
| 2026-06-1216:30 ET | 8-K | 5.07 Shareholder vote results | 0001493152-26-028458 |
| 2026-06-1207:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-26-028369 |
| 2026-06-1016:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-028106 |
| 2026-06-0407:30 ET | 8-K | 8.01 Other events | 0001493152-26-027197 |
| 2026-05-1307:35 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-022614 |
| 2026-05-1307:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-022610 |
| 2026-04-2716:30 ET | DEF 14A | Proxy statementPeriod 2026-04-27 | 0001493152-26-019153 |
| 2026-04-0708:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-015451 |
| 2026-03-2016:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-011863 |
| 2026-03-1707:36 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-010413 |
| 2026-03-1707:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-010408 |
| 2026-03-0907:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-009299 |
| 2025-11-1207:35 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-021723 |
| 2025-11-1207:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-021721 |
| 2025-08-1407:31 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-023716 |
| 2025-08-1407:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-023715 |
| 2025-07-1816:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001641172-25-020227 |
| 2025-07-0207:30 ET | 8-K | 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-017460 |
| 2025-05-1916:15 ET | 8-K | 5.07 Shareholder vote results | 0001641172-25-011452 |
| 2025-05-1507:35 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-010516 |
| 2025-05-1507:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-010514 |
| 2025-05-1207:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-009564 |
| 2025-04-2908:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-006584 |
| 2025-04-2906:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-006548 |
| 2025-04-0916:15 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001641172-25-003411 |
| 2025-03-2007:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-010981 |
| 2025-03-2007:30 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001493152-25-010978 |
| 2024-12-2016:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-051060 |
| 2024-11-1407:30 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-045340 |
| 2024-11-1407:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-045338 |
| 2024-11-1217:24 ET | DEF 14A | Proxy statementPeriod 2024-11-12 | 0001493152-24-044862 |
| 2024-11-1207:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-044514 |
| 2024-10-2907:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-042775 |
| 2024-08-1407:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-031862 |
| 2024-08-1207:35 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-031150 |
| 2024-08-1207:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-031146 |
| 2024-07-0916:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-24-026640 |
| 2024-05-1507:35 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-019459 |
| 2024-05-1507:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-019449 |
| 2024-05-0317:16 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-017768 |
| 2024-05-0306:45 ET | 8-K | 2.02 Results of operations; 8.01 Other events | 0001493152-24-017625 |
| 2024-04-2416:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-015792 |
| 2024-04-2216:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-015531 |
| 2024-03-1907:19 ET | DEF 14A | Proxy statementPeriod 2024-03-19 | 0001493152-24-010421 |
| 2024-03-1808:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-010206 |
| 2024-03-1807:35 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-010190 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:56 ET. Listed shows no prices and gives no investment advice.